World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
49319
World Ranking
11522
National Ranking
5910

Overview

Lawrence S. Honig is affiliated with Columbia University in the United States. Their research primarily focuses on medicine, with a strong emphasis on physiology, psychiatry and mental health, neurology, molecular biology, and cognitive neuroscience.

The scientist's work covers multiple key topics, including:

  • Alzheimer's disease research and treatments
  • Dementia and Cognitive Impairment Research
  • Functional Brain Connectivity Studies
  • Parkinson's Disease Mechanisms and Treatments
  • Advanced Neuroimaging Techniques and Applications
  • Bioinformatics and Genomic Networks
  • Health, Environment, Cognitive Aging

Lawrence S. Honig has published extensively in respected scientific venues. The most frequent publication outlets include:

  • Alzheimer s & Dementia (61 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (18 publications)
  • Nature Communications (10 publications)
  • Neurology (8 publications)
  • The Lancet Neurology (5 publications)

Their recent scientific papers demonstrate involvement in neurodegenerative disease research and genetic studies. Selected papers include:

  • Research criteria for the diagnosis of prodromal dementia with Lewy bodies, 2020, Neurology
  • Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease, 2020, Nature Communications
  • Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study, 2020, Nature Communications
  • Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture, 2021, Nature Genetics
  • A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease, 2021, Nature Medicine

Collaborative efforts have been significant in their career. Frequent co-authors include:

  • Clifford R. Jack
  • John C. Morris
  • Robert A. Koeppe
  • Gregory S. Day
  • Chiadi U. Onyike

Best Publications

  • Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium

    Ian G. McKeith;Bradley F. Boeve;Dennis W. DIckson;Glenda Halliday

  • Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

    Maarten J Titulaer;Lindsey McCracken;Iñigo Gabilondo;Thaís Armangué

  • Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

    Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang

  • Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

    Stephen Salloway;Reisa Sperling;Nick C. Fox;Kaj Blennow

  • Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

    Y. Iturria-Medina;R. C. Sotero;P. J. Toussaint;J. M. Mateos-Pérez

  • Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

    Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez

  • Aggregation of vascular risk factors and risk of incident Alzheimer disease.

    Jose Luchsinger;Christiane Reitz;Larry S. Honig;Ming-Xin Tang

  • Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease

    Lawrence S Honig;Bruno Vellas;Michael M Woodward;Mercè Boada

  • Hippocampal and entorhinal atrophy in mild cognitive impairment Prediction of Alzheimer disease

    D. P. Devanand;G. Pradhaban;X. Liu;A. Khandji

  • A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.

    S. Salloway;R. Sperling;S. Gilman;N.C.I. Fox

  • Research criteria for the diagnosis of prodromal dementia with Lewy bodies

    Ian G. McKeith;Tanis J. Ferman;Alan J. Thomas;Frédéric Blanc

  • Comparative lipidomic analysis of mouse and human brain with Alzheimer disease.

    Robin B. Chan;Tiago Gil Oliveira;Etty P. Cortes;Lawrence S. Honig

  • Four distinct trajectories of tau deposition identified in Alzheimer’s disease

    Jacob W Vogel;Alexandra L Young;Neil P Oxtoby;Ruben Smith

  • Interplay of LRRK2 with chaperone-mediated autophagy

    Samantha J. Orenstein;Sheng-Hang Kuo;Inmaculada Tasset;Esperanza Arias

  • Neuropathological changes in essential tremor: 33 cases compared with 21 controls

    Elan D. Louis;Phyllis L. Faust;Jean Paul G. Vonsattel;Lawrence S. Honig

  • Plasma Aβ40 and Aβ42 and Alzheimer’s disease: Relation to age, mortality, and risk

    Richard Paul Mayeux;Lawrence S. Honig;Mingxin Tang;Jennifer J. Manly

  • Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis

    Reisa Sperling;Stephen Salloway;David J Brooks;Donatella Tampieri

  • A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies

    Michael A. Nalls;Raquel Duran;Grisel Lopez;Marzena Kurzawa-Akanbi

  • Model-guided microarray implicates the retromer complex in Alzheimer's disease.

    Scott A. Small;Kelly Kent;Aimee Pierce;Conrad Leung

  • Stroke and the risk of Alzheimer disease.

    Lawrence S. Honig;Mingxin Tang;Steven M. Albert;Rosanne Costa

Frequent Co-Authors

Yaakov Stern
Yaakov Stern Columbia University
John C. Morris
John C. Morris Washington University in St. Louis
Richard Mayeux
Richard Mayeux Columbia University
Jean Paul Vonsattel
Jean Paul Vonsattel Columbia University
Karen Marder
Karen Marder Columbia University
Peter St George-Hyslop
Peter St George-Hyslop Columbia University
Marilyn S. Albert
Marilyn S. Albert Johns Hopkins University School of Medicine
John Q. Trojanowski
John Q. Trojanowski University of Pennsylvania
Douglas Galasko
Douglas Galasko University of California, San Diego
Tatiana Foroud
Tatiana Foroud Indiana University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Medicine but seeking diverse career options, online degree pathways offer great flexibility and affordability. Many students are now turning to online healthcare administration programs to develop the leadership and management skills needed for administrative roles in hospitals, clinics, and health agencies.

If you are looking to further your expertise, exploring the cheapest online mha (Master’s in Healthcare Administration) options can be a smart move. Earning this degree online allows for continued professional development without pausing your career.

Aspiring nurses can advance by enrolling in the cheapest dnp online programs, achieving a Doctor of Nursing Practice with reduced tuition costs. This credential is highly valued for leadership and advanced clinical practice positions.

Finally, for those interested in pharmacy careers, there are flexible pharmacy school online options. These programs enable learners to earn advanced pharmacy credentials from the comfort of home, often at a lower price point.

Best Scientists Citing Lawrence S. Honig

Trending Scientists